Hzymes is pleased to announce our participation in the 2026 China Food, Drug, Medical Device and Cosmetics New Quality Productivity and High-Quality Development Conference, taking place from May 8–11, 2026, at the Mangrove Tree Resort World Conference Center in Sanya, Hainan, China.

As a leading innovator in core raw materials for biopharmaceutical applications, Hzymes will also co-host a featured parallel forum alongside leading industry partners:

"What Are the Boundaries of mRNA Technology Applications?"

This high-level forum will bring together experts from academia, industry, and research institutions to explore the evolving landscape of mRNA therapeutics, emerging opportunities, and the scientific, technical, and regulatory challenges shaping the future of the field.

Exploring the Next Frontier of mRNA Innovation

mRNA technology has rapidly emerged as a transformative platform in modern medicine, driving breakthroughs in infectious disease prevention, oncology, and rare disease treatment. Its potential continues to expand into cutting-edge areas such as in vivo CAR-T, gene editing, and other next-generation therapeutic modalities.

At the same time, several key challenges remain, including delivery efficiency, expression stability, systemic inflammatory responses, cold-chain dependence, and manufacturing cost. Addressing these limitations will be essential to unlocking broader clinical adoption and global accessibility.

Forum Theme

Unlocking the Full Potential of mRNA Through Core Technologies and AI Innovation

Key discussion topics will include:

• Foundational technologies enabling the next generation of mRNA therapeutics
• How AI is accelerating innovation across mRNA development workflows
• The regulatory impact of China's Order No. 818 on the mRNA industry
• Strategies for overcoming technical and commercialization barriers

The forum will be convened by Professor Hui Aimin, a returning scientist who played a leading role in the co-development and commercialization of the world's first mRNA COVID-19 vaccine in Greater China.

Featured Presentation by Dr. Guangyu Yang

As part of the forum program, Dr. Guangyu Yang, Founder and CTO of Hzymes, will deliver a keynote presentation highlighting the critical role of enzyme innovation in advancing next-generation mRNA and cell therapies.

Drawing on Hzymes' deep expertise in biopharmaceutical raw materials, Dr. Yang will discuss how advanced enzyme technologies can help overcome key challenges in delivery, expression, and scalable manufacturing—enabling broader access to transformative therapies.

Event Details

Conference Dates: May 8–11, 2026
Venue: Mangrove Tree Resort World Conference Center, Sanya, Hainan, China

Co-Organizers of the Parallel Forum

• Hzymes Biotech
• Professor Hui Aimin's Team (Huizhengqi Pharmaceutical)
• WuXi AppTec Co., Ltd.
• KACTUS Biotech

Supporting Organization

• Vazyme Biotech Co., Ltd.

We look forward to connecting with innovators, researchers, and industry leaders in Sanya as we explore the future of mRNA therapeutics and biopharmaceutical innovation.

Join Hzymes Biotech in shaping the next chapter of mRNA technology.